시간 외 거래: 18.98

펄스 바이오 (PLSE)

Pulse Biosciences Inc 주식(PLSE)의 최신 뉴스

펄스 바이오 (PLSE)

Pulse Biosciences Inc 주식(PLSE)의 최신 뉴스

Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up to $18.51 - Defense World

Quest Partners LLC Purchases New Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up to $18.51 - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Shares Down 2.7% - Defense World

Pulse Biosciences (NASDAQ:PLSE) Shares Down 2.7% - MarketBeat

Keeping an Eye on Pulse Biosciences Inc (PLSE) After Insider Trading Activity - Knox Daily

Pulse Biosciences (NASDAQ:PLSE) Trading Up 7% - MarketBeat

Paul LaViolette Joins Pulse Bioscience's Board Of Directors - MPO-mag

Pulse Biosciences (NASDAQ:PLSE) Trading Down 9.6% - MarketBeat

Pulse Biosciences Inc (PLSE) may enjoy gains as insiders got busy in the recent days - Knox Daily

Ratios in Focus: Analyzing Pulse Biosciences Inc (PLSE)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Pulse Biosciences Inc [PLSE] Investment Guide: What You Need to Know - Knox Daily

(PLSE) Technical Data - Stock Traders Daily

Seborrheic Keratosis Treatment Market Report 2024-2030, - GlobeNewswire

Seborrheic Keratosis Treatment Market Report 2024-2030, Featuring Comprehensive Profiles of Aclaris - Daily Guardian Canada

Pulse Biosciences (NASDAQ:PLSE) Trading Down 8.1% - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $19.96 - Defense World

Pulse Biosciences (NASDAQ:PLSE) Trading Up 3.9% - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Stock Quotes, Forecast and News Summary - Benzinga

PLSE Stock Earnings: Pulse Biosciences Reported Results for Q2 2024 - InvestorPlace

Griffin Asset Management Inc. Sells 42,641 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Reaches New 12-Month High at $21.00 - Defense World

Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $19.96 - MarketBeat

Investing in Pulse Biosciences Inc (PLSE): What You Must Know - Knox Daily

Pulse Biosciences (NASDAQ:PLSE) Reaches New 52-Week High at $21.00 - MarketBeat

Pulse Biosciences stock hits 52-week high at $20.51 - Investing.com

Pulse Biosciences stock hits 52-week high at $20.51 By Investing.com - Investing.com Canada

Pulse Biosciences stock hits 52-week high at $20.51 By Investing.com - Investing.com Australia

Price T Rowe Associates Inc. MD Buys Shares of 10,009 Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Cetera Advisors LLC Invests $109,000 in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Vanguard Group Inc. Buys 189,227 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Vanguard Group Inc. Increases Stock Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Stock Price Up 8% - MarketBeat

Taking a Closer Look At Pulse Biosciences Inc (PLSE) Following Its Recent Trade - Knox Daily

Paul LaViolette joins Pulse Biosciences as co-chairman By Investing.com - Investing.com Australia

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q2 2024 Earnings Call Transcript - Insider Monkey

Paul LaViolette joins Pulse Biosciences as co-chairman - Investing.com India

Paul LaViolette joins Pulse Biosciences as co-chairman - Investing.com

Pulse Biosciences Inc (PLSE) Q2 2024 Earnings Call Transcript Hi - GuruFocus.com

Earnings call: Pulse Biosciences details progress on nano-PFA devices By Investing.com - Investing.com Canada

Earnings call: Pulse Biosciences details progress on nano-PFA devices - Investing.com

Pulse Biosciences successfully treats first patients with nano-PFA cardiac surgery system - Cardiac Rhythm News

Pulse Biosciences Inc. (PLSE) Q2 2024 Earnings Call Transcript - Seeking Alpha

Paul LaViolette joins Pulse Biosciences as co-chairman By Investing.com - Investing.com UK

Pulse Biosciences Highlights CellFX™ Advances in Presentation - TipRanks

Pulse Biosciences Enhances Board with Strategic Leadership Changes - TipRanks

Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results - StockTitan

Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors - The Bakersfield Californian

Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors - StockTitan

Pulse Biosciences launches first-in-human pulsed field ablation trial - Clinical Trials Arena

Pulse Biosciences launches first-in-human pulsed field ablation trial - Medical Device Network

Pulse Biosciences (NASDAQ:PLSE) Trading Up 18% - MarketBeat

Pulse Bio Treats First-in-Human Patients With Nano-PFA Cardiac Surgery System - MPO-mag

Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System - StockTitan

Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System - Business Wire

Pulse Biosciences (NASDAQ:PLSE) Upgraded to Sell at StockNews.com - Defense World

Pulse Bio Wins FDA Breakthrough Nod For CellFX NsPFA To Treat AFib - MPO-mag

Pulse Biosciences (NASDAQ:PLSE) Stock Rating Upgraded by StockNews.com - MarketBeat

Pulse Biosciences (PLSE) Set to Announce Earnings on Monday - MarketBeat

Pulse Biosciences (PLSE) Set to Announce Quarterly Earnings on Monday - Defense World

How To Trade (PLSE) - Stock Traders Daily

Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences - StockTitan

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Pulse Biosciences, Inc. (NASDAQ: PLSE) - Longview News-Journal

PLSE과 유사한 종목